Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Supor Pharmaceutical Co., Ltd. is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) and chemical intermediates, operating as a core member of the Supor Group's healthcare division. Based in Yancheng, Jiangsu Province, the company maintains a significant production footprint dedicated to high-quality synthesis under stringent GMP standards. Its primary therapeutic focus includes cardiovascular health, where it produces leading statin medications, and infectious diseases, specifically chronic hepatitis B treatments. The company provides comprehensive CDMO services, supporting global partners from process development through to commercial-scale manufacturing. By integrating advanced chemical technologies with robust quality management systems, Jiangsu Supor has established itself as a reliable supplier in the international pharmaceutical supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Supor Pharmaceuticals.